SiTime Corporation SITM 深 滬
等待開盤 03-26 09:30:00 美东时间
354.50
+0.150
+0.04%
華盛通- 最 高375.275
- 今 開359.42
- 成交量 33.00万股
- 最 低 345.79
- 昨 收 354.35
- 總市值 93.23亿
- 52周最高 446.955
- 市盈率 靜 --
- 換手率 1.25%
- 52周最低 108.695
- 委 比 3.70%
- 總股本 2629.99万
- 歷史最高 446.955
- 量 比 0.31
- 振 幅 8.32%
- 歷史最低 15.42
- 每 手 1
- 風險率 80.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SiTime Signs Long-Term Lease For New Santa Clara Headquarters
SiTime Corporation ( ($SITM) ) has provided an announcement. On March 23, 2026,...
03-25 05:44
Shares of semiconductor companies are trading lower amid overall market weakness due to the ongoing conflict in the Middle East. The industry may be pulling back due to high energy costs that may disrupt the chipmaking process.
Shares of semiconductor companies are trading lower amid overall market weaknes...
03-12 23:53
SiTime EVP of Marketing Piyush B Sevalia Disposes of Common Shares
SiTime EVP of Marketing Piyush B Sevalia Disposes of Common Shares Piyush B Sevalia, EVP, Marketing of SiTime Corporation, reported a disposal of common shares. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generat
02-20 08:14
偷偷挣钱的芯片巨头
英伟达的成功故事，本质上是一个产业生态的胜利。黄仁勋固然是聚光灯下的主角，但撑起这座AI帝国的，是各大供应商的不懈投入与齐心协力。AI背后这条隐形的产业链将全球数百家企业、数十万工程师的命运紧紧绑定。
02-12 09:39
SiTime Director Akira Takata Reports Sale of Common Shares
SiTime Director Akira Takata Reports Sale of Common Shares Akira Takata, Director, reported a disposal of common shares of SiTime Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial int
02-11 06:58
Neuronetics Reports Q4 Preliminary Revenue $41.8M, FY25 Revenue $149.2M
Neuronetics, Inc., (NASDAQ:STIM) (the "Company" or "Neuronetics") a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients
02-11 05:36
美股大行评级 | 谷歌绩后获14家大行上调目标价；Arm、高通、波士顿科学、艾可菲、Snap、优步遭多家大行下调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Wave Life Sciences Ltd."超配"评级，目标价从34美元升至41美元；Piper Sandler：维持Replimune Group"超配"评级，目标价从13美元升至14美元
02-06 16:52
美股牛股 | 绩优股飙升！精密计时龙头SiTime涨近18%，Q4财报超预期；麦克森药物批发涨超16%
绩优股飙升！精密计时龙头SiTime涨近18%，Q4财报超预期同时公布重大收购；麦克森药物批发涨超16%，26Q3业绩超预期；恩赛因绩后涨近14%>>
02-06 15:30
